Alzheimer’s drug shows promise in early results of study
Автор: China Daily Global
Загружено: 2022-09-29
Просмотров: 9
Japan’s pharmaceutical company Eisai and US biotech company Biogen said on Tuesday that their joint Alzheimer’s treatment, which appeared to slow the fatal disease in a late-stage study, has been submitted to the US Food and Drug Administration for accelerated approval.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: